BioTime Inc (NYSE MKT LLC:BTX)

4.93
Delayed Data
As of Apr 01
 -0.04 / -0.80%
Today’s Change
2.21
Today|||52-Week Range
5.70
+32.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-16.5M-21.4M-43.9M--
 
 
 
 
Depreciation3.1M2.8M4.0M--
 
 
 
 
Total Other Cash Flow-177.1K-1.6M10.9M--
 
 
 
 
Funds From Operations-13.6M-20.1M-32.3M--
 
 
 
 
Funds From/For Other Operating Expenses-26.1K-468.0K-2.8M--
 
 
 
 
Net Cash Flow - Operating Activities-13.6M-19.7M-29.5M--
 
 
 
 
 
InvestingDecrease In Investments0.00292.4K0.00--
 
 
Capital Expenditures-960.3K-400.8K-2.3M--
 
 
 
 
Fixed Asset Disposal5.9K4.5K30.9K--
 
 
 
 
Net Assets From Acquisitions -246.9K0.00-978.1K--
 
 
 
Other Investing - Uses-1.5K-764.00-441.2K--
 
 
 
 
Other Investing - Sources10.00------
 
 
Net Cash Flow Investing-1.2M-104.7K-3.7M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale3.9M1.9M34.3M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing3.9M1.9M34.3M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-178.8K8.9K56.1K--
 
 
 
 
 
Net Change In Cash-10.9M-17.9M1.1M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account